International invited Speakers:

• Tom Freeman, MRC Human Genome Mapping Programme, Cambridge
• Dolores Cahill, MPI, Berlin
• Ken-ichi Arai, Japan
• Gabor Lamm, EMBLEM, Germany

Session 1: Fast-Tracking Research with DNA arrays

• Tom Freeman, MRC Human Genome Mapping Programme, Cambridge
  Prospects for microarray analysis in an academic setting
• Charles Mackay, Garvan Medical Research Institute, Sydney
  Affymetrix gene profiling for inflammatory diseases, and integration with Celera database, SNP detection, and disease association
• Andrew Holloway, PeterMac, Melbourne
  Gene arrays and cancer classification
• Martin McCall, Centre for Immunology
  Complete human genome screen for novel anti-inflammatory targets

Session 2: Stem Cells, development, and biotechnology 

• Peter Rathjen, University of Adelaide
  Stem cells and the future of medicine
• Hirofumi Doi, Celestar  Lexico-Sciences
  A slant on stem cells, learned from gene expression of mouse early embryos

Session 3: Commercialising Biodiscovery

• David Adamthwaite, Baldwin Shelston Waters
  Protect or publish?
• Lee Ridge, Photonics CRC
  Linking Research to Finance
• Mark Bradley, ATP-Innovations
  The long and winding road: biotechnology commercialisation in Australia

Session 4: Evolution of a Biotech Company

• Peter Colman, Biota
  Early history of Biota
• Peter Gage, Biotron
  Commercialisation of university research: from academia to the ASX

Session 5: Biotechnology platforms of the 21st Century

• Richard Harrison, Applera
  Faster, stronger, higher; the technologies driving the genomic revolution.
• Bruce Cornell, AMBRI
  Biosensors
• Andrew Gooley, Proteome Systems
  ProteomIQ - an automated and integrated proteomic platform

Session 6: Proteomics

• Dolores Cahill, MPI, Berlin
  Protein arrays: Generation and applications
• Richard Simpson, Ludwig Institute, Melbourne
  Protein analysis beyond 2D gels
• John Whitelock, CSIRO
  Proteomic analysis of proteoglycans

Session 7: Arrays in novel applications

• Robyn Ward, St Vincent's Hospital, Sydney
  New cancer therapies, the cup runneth over
• Richard Christopherson, University of Sydney
  Immunophenotyping of leukemias using a cluster of differentiation antibody microarray
• Els N Meeusen, University of Melbourne
  Novel sheep asthma model for drug discovery and formulation

Session 8: Global Biotechnology Opportunities

• Ken-ichi Arai, Japan
  Pacific Rim Biotechnology
• Eugen Takagi, Xcelerator, Japan
  Japanese bio venture today and strong needs of overseas collaboration
• Gabor Lamm, EMBLEM, Germany
  Innovation to Commercialisation: A European Perspective